MoonLake Immunotherapeutics Trims Stake: Investor Watch
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
Want to earn money from home free? Discover practical ideas to generate income without any financial commitment.
17,986 articlesWhen a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
SpaceX IPO chatter has investors buzzing and critics worried. This piece breaks down why the hype could outpace reali...
In a year of AI-driven demand, SOXX outpaced XSD thanks to a cap-weighted tilt toward megacaps. The gap highlights ho...
New disclosures on trump crypto ties allegations put regulatory scrutiny back in focus, as crypto markets react and i...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
Energy stocks are staging a comeback in 2026 as crude oil recovers and demand improves. The IYE ETF leads gains, sign...
America is racing to rebuild its nuclear fuel chain as the next generation of reactors edges toward reality. The move...
A potential shift away from the Fed’s traditional guidance could redefine how markets price risk. If kevin warsh read...
The U.S. government has imposed export controls on Anthropic’s Fable and Mythos, effectively creating a licensing reg...
A senior AI executive is leaving Meta Platforms, adding to tech worries. On Wednesday, the stock fell more than 5%, p...
A bold claim about a $22.7 trillion enterprise AI opportunity could reshape portfolios. This piece breaks down the th...
By late 2025, roughly 12% of U.S. adults were using GLP-1 weight-loss medications, a trend that is quietly trimming g...